Peptide Receptor Radionuclide Therapy (PRRT) Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors

OBJECTIVES: The objective of this study was to describe the outcomes of patients in the University of Iowa (UI) Neuroendocrine Tumor (NET) Database treated with peptide receptor radionuclide therapy (PRRT). METHODS: 135 patients from the UI NET Database who received PRRT were analyzed, their charact...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pancreas
Main Authors: Sharma, Nancy, Naraev, Boris G., Engelman, Eric S., Zimmerman, M. Bridget, Bushnell, David L., O’Dorisio, Thomas M., O’Dorisio, M. Sue, Menda, Yusuf, Müller-Brand, Jan, Howe, James R., Halfdanarson, Thorvardur R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5595066/
https://ncbi.nlm.nih.gov/pubmed/27759712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000000734
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados